PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial

@inproceedings{Chapal2015PREventingDG,
  title={PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial},
  author={Marion Chapal and Yohann Foucher and Monique Marguerite and Karine Neau and Emmanuelle Papuchon and Pascal Daguin and E. Morelon and Georges Mourad and Elisabeth Cassuto and Marc Ladri{\`e}re and Christophe M Legendre and Magali Giral},
  booktitle={Trials},
  year={2015}
}
BackgroundIn kidney transplantation, the use of Anti-Thymocyte Globulins (ATG) as induction therapy has been described as a possible treatment for reducing the prevalence of Delayed Graft Function (DGF). ATG possesses pharmaceutical proprieties that could help control the lesions caused by ischemia reperfusion injury. However, other studies have questioned this potential protective effect. We hypothesized that the benefits related to ATG for reducing DGF prevalence may be higher and more… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

A Language and environment for statistical computing. R Foundation for Statistical Computing Vienna, Austria

R R Core Team
  • 2010
VIEW 1 EXCERPT

Prediction of delayed graft function after renal transplantation.

  • Canadian Urological Association journal = Journal de l'Association des urologues du Canada
  • 2009
VIEW 1 EXCERPT

with cyclosporine triple immunosuppression : efficacy and safety

AJ Turunen, L Lindgren, +3 authors SM Siitonen
  • 2007